If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Robert Aiken is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Glioblastoma Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences
Astrocytoma Medicine & Life Sciences
Phase III Clinical Trials Medicine & Life Sciences
IGF Type 1 Receptor Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Nervous System Medicine & Life Sciences
Cytarabine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2019

  • 558 Citations
  • 10 h-Index
  • 15 Article
  • 3 Comment/debate
  • 2 Editorial
  • 1 Review article

A randomized double-blind placebo-controlled phase II trial of dendritic cell vaccine ICT-107 in newly diagnosed patients with glioblastoma

Wen, P. Y., Reardon, D. A., Armstrong, T. S., Phuphanich, S., Aiken, R. D., Landolfi, J. C., Curry, W. T., Zhu, J. J., Glantz, M., Peereboom, D. M., Markert, J. M., LaRocca, R., O'Rourke, D. M., Fink, K., Kim, L., Gruber, M., Lesser, G. J., Pan, E., Kesari, S., Muzikansky, A. & 3 others, Pinilla, C., Santos, R. G. & Yu, J. S., Oct 1 2019, In : Clinical Cancer Research. 25, 19, p. 5799-5807 9 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Glioblastoma
Dendritic Cells
Vaccines
Placebos
HLA-A2 Antigen

Correction: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma [J Transl Med., 16, (2018) (142)] DOI: 10.1186/s12967-018-1507-6

Liau, L. M., Ashkan, K., Tran, D. D., Campian, J. L., Trusheim, J. E., Cobbs, C. S., Heth, J. A., Salacz, M., Taylor, S., D'Andre, S. D., Iwamoto, F. M., Dropcho, E. J., Moshel, Y. A., Walter, K. A., Pillainayagam, C. P., Aiken, R., Chaudhary, R., Goldlust, S. A., Bota, D. A., Duic, P. & 49 others, Grewal, J., Elinzano, H., Toms, S. A., Lillehei, K. O., Mikkelsen, T., Walbert, T., Abram, S. R., Brenner, A. J., Brem, S., Ewend, M. G., Khagi, S., Portnow, J., Kim, L. J., Loudon, W. G., Thompson, R. C., Avigan, D. E., Fink, K. L., Geoffroy, F. J., Lindhorst, S., Lutzky, J., Sloan, A. E., Schackert, G., Krex, D., Meisel, H. J., Wu, J., Davis, R. P., Duma, C., Etame, A. B., Mathieu, D., Kesari, S., Piccioni, D., Westphal, M., Baskin, D. S., New, P. Z., Lacroix, M., May, S. A., Pluard, T. J., Tse, V., Green, R. M., Villano, J. L., Pearlman, M., Petrecca, K., Schulder, M., Taylor, L. P., Maida, A. E., Prins, R. M., Cloughesy, T. F., Mulholland, P. & Bosch, M. L., Jun 29 2018, In : Journal of translational medicine. 16, 1, 179.

Rutgers, The State University

Research output: Contribution to journalComment/debate

Phase III Clinical Trials
Glioblastoma
Dendritic Cells
Names
Vaccines
44 Citations (Scopus)

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Liau, L. M., Ashkan, K., Tran, D. D., Campian, J. L., Trusheim, J. E., Cobbs, C. S., Heth, J. A., Salacz, M., Taylor, S., D'Andre, S. D., Iwamoto, F. M., Dropcho, E. J., Moshel, Y. A., Walter, K. A., Pillainayagam, C. P., Aiken, R., Chaudhary, R., Goldlust, S. A., Bota, D. A., Duic, P. & 49 others, Grewal, J., Elinzano, H., Toms, S. A., Lillehei, K. O., Mikkelsen, T., Walpert, T., Abram, S. R., Brenner, A. J., Brem, S., Ewend, M. G., Khagi, S., Portnow, J., Kim, L. J., Loudon, W. G., Thompson, R. C., Avigan, D. E., Fink, K. L., Geoffroy, F. J., Lindhorst, S., Lutzky, J., Sloan, A. E., Schackert, G., Krex, D., Meisel, H. J., Wu, J., Davis, R. P., Duma, C., Etame, A. B., Mathieu, D., Kesari, S., Piccioni, D., Westphal, M., Baskin, D. S., New, P. Z., Lacroix, M., May, S. A., Pluard, T. J., Tse, V., Green, R. M., Villano, J. L., Pearlman, M., Petrecca, K., Schulder, M., Taylor, L. P., Maida, A. E., Prins, R. M., Cloughesy, T. F., Mulholland, P. & Bosch, M. L., May 29 2018, In : Journal of translational medicine. 16, 1, 1 p., 142.

Rutgers, The State University

Research output: Contribution to journalArticle

Phase III Clinical Trials
Glioblastoma
temozolomide
Dendritic Cells
Vaccines

A 54-Year-Old Male with Multiple Intracranial and Extracranial Masses

Lin, D. M., Diaz, A. Z., Aiken, R., Gattuso, P. & Nag, S., Sep 1 2017, In : Brain Pathology. 27, 5, p. 693-694 2 p.

Rutgers, The State University

Research output: Contribution to journalArticle

32 Citations (Scopus)

First-in-human clinical trial of oral ONC201 in patients with refractory solid tumors

Stein, M., Bertino, J., Kaufman, H. L., Mayer, T., Moss, R., Silk, A., Chan, N., Malhotra, J., Rodriguez-Rust, L., Aisner, J., Aiken, R., Haffty, B., DiPaola, R. S., Saunders, T., Damare, S., Beckett, Y., Yu, B., Najmi, S., Gabel, C., Dickerson, S. & 6 others, Zheng, L., El-Deiry, W. S., Allen, J. E., Stogniew, M., Oster, W. & Mehnert, J., Aug 1 2017, In : Clinical Cancer Research. 23, 15, p. 4163-4169 7 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Clinical Trials
Neoplasms
Pharmacokinetics
Keratin-18
Endometrial Neoplasms